✦ LIBER ✦

149 Phase II study of taxotere monotherapy in non small cell lung cancer (NSCLC)

✍ Scribed by Alexopoulos, C.; Rigatos, G.; Efremidou, A.; Vaslamatzis, M.; Alexopoulos, A.; Koumakis, G.; Patila, E.; Xynogalos, S.; Stavrakskis, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of gemcitabine in non sma

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Gemzar monotherapy in advanced non-small

✍ Gutorov, S.; Basin, I.; Semenov, N.; Bulat, Y.; Zharkov, S. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 84 KB

1096 Preliminary report of a phase II st

✍ Douillard, J.Y.; Monnier, A.; Ibrahim, N.; Belli, L.; Sun, X.S.; Soulas, F.; Boy 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Taxotere™ (docetaxel: DTXL), an active a

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Docetaxel (Taxotere®) in the management

✍ Miller, Vincent A. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Phase II study of oxaliplatin in poor-pr

✍ I Monnet; S Brienza; F Hugret; S Voisin; J Gastiaburu; J.C Saltiel; P Soulié; J. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 56 KB